Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Hikaru Nagahara is active.

Publication


Featured researches published by Hikaru Nagahara.


Nature Medicine | 1998

Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migration.

Hikaru Nagahara; Adamina Vocero-Akbani; Eric L. Snyder; Alan Ho; Dawn G. Latham; Natalie A. Lissy; Michelle Becker-Hapak; Sergei A. Ezhevsky; Steven F. Dowdy

Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27 Kip1 induces cell migration


Biochemical and Biophysical Research Communications | 2003

Cell adhesion aside from integrin system can abrogate anoikis in rat liver cells by down-regulation of FasL expression, not by activation of PI-3K/Akt and ERK signaling pathway

Koji Ishida; Hikaru Nagahara; Tomomi Kogiso; Tomoko Aso; Naoaki Hayashi; Toshihiro Akaike

Epithelial cells require contact with extracellular matrix (ECM) to inhibit detachment-induced apoptosis (anoikis). The ERK and PI-3K/Akt signaling pathways have been identified to inhibit anoikis. We present here a different story. An adult rat liver cell line, ARLJ301-3, underwent apoptosis within 4h under suspension conditions even with active forms of Akt and ERK1/2. Once ARLJ301-3 cells are plated on tissue culture plates coated with synthetic polymer, such as poly-(N-p-vinyl benzyl-O-beta-D-galactopyranosyl-D-gluconamide) (PVLA), poly-L-lysine or polystyrene, instead of functional ECM such as fibronectin, they could survive and proliferate without activation of Akt and ERK1/2. The expression of Fas receptor ligand (FasL) is specifically detected in cells under suspension conditions or treated with cytochalasin-D. We present here the first report that FasL expression is up-regulated by the cytoskeletal disruption directed by cytochalasin-D treatment or cell detachment from ECM.


Hepatology International | 2013

Transdifferentiation of human fibroblasts into hepatocyte-like cells by defined transcriptional factors.

Tomomi Kogiso; Hikaru Nagahara; Motoyuki Otsuka; Keiko Shiratori; Steven F. Dowdy

PurposeLiver transplantation is currently the only curative therapeutic option for end-stage liver cirrhosis. However, due to the limitations of donor liver availability and occasional rejection, it cannot always be successfully applied. In this study, we determined whether fibroblasts can be transdifferentiated into hepatocyte-like cells by transcription factors that initiate and maintain hepatocyte differentiation.MethodsFibroblasts were transduced with retrovirus vectors carrying FOXA2, HNF4α, and C/EBPβ. To enhance the efficiency of transdifferentiation, cMyc was also expressed.ResultsTransdifferentiation was successful using both neonatal fibroblasts and human forehead fibroblasts. The transdifferentiated cells produced hepatocyte-specific proteins such as albumin and cytochrome, and had important hepatocyte-specific functions, such as glycogen storage and indocyanine green uptake, suggesting that the cells function at least as partial hepatocytes.ConclusionsThese results provide a novel method of generating differentiated hepatocyte-like cells, and may represent an alternative source of cells for future cell-based therapeutics for end-stage liver diseases.


PLOS ONE | 2014

Efficient Induction of Apoptosis by Wee1 Kinase Inhibition in Hepatocellular Carcinoma Cells

Tomomi Kogiso; Hikaru Nagahara; Etsuko Hashimoto; Shun-ichi Ariizumi; Masakazu Yamamoto; Keiko Shiratori

Transforming growth factor-β1 (TGF-β1) potently inhibits human hepatocellular carcinoma (HCC) cell growth. Here we demonstrated that TGF-β1-induced apoptosis is mediated by decreased phosphorylation of cdc2 at Tyr15 accompanied by down-regulation of Wee1 kinase expression. As expected from these results, a Wee1 kinase inhibitor efficiently induced apoptosis in HCC cells in the absence of TGF-β1 treatment. In surgically resected samples, Wee1 kinase was expressed in moderately to poorly differentiated HCC, whereas no Wee1 kinase expression was observed in non-cancerous tissue, including cirrhotic tissue. Our results suggest that Wee1 kinase inhibitors may be a practical novel therapeutic option against advanced HCC.


World Journal of Gastroenterology | 2014

Risk factors associated with Barrett's epithelial dysplasia.

Mikiko Fujita; Yuri Nakamura; Saeko Kasashima; Maiko Furukawa; Ryoichi Misaka; Hikaru Nagahara

AIM To elucidate risk factors associated with dysplasia of short-segment Barretts esophagus (BE). METHODS A total of 151 BE patients who underwent endoscopic examination from 2004 to 2008 in Aoyama Hospital, Tokyo Womens Medical University, Japan and whose diagnosis was confirmed from biopsy specimens were enrolled in the study. BE was diagnosed based on endoscopic findings of gastric-appearing mucosa or apparent columnar-lined esophagus proximal to the esophagogastric junction. Dysplasia was classified into three grades - mild, moderate and severe - according to the guidelines of the Vienna Classification System for gastrointestinal epithelial neoplasia. Anthropometric and biochemical data were analyzed to identify risk factors for BE dysplasia. The prevalence of Helicobacter pylori (H. pylori) infection and the expression of p53 by immunohistological staining were also investigated. RESULTS Histological examination classified patients into three types: specialized columnar epithelium (SCE) (n = 65); junctional (n = 38); and gastric fundic (n = 48). The incidence of dysplasia or adenocarcinoma from BE of the SCE type was significantly higher than that of the other two types (P < 0.01). The univariate analysis revealed that sex, H. pylori infection, body weight, p53 overexpression, and low diastolic blood pressure (BP) were associated with BE dysplasia. In contrast, body mass index, waist circumference, metabolic syndrome complications, and variables related to glucose or lipid metabolism were not associated with dysplasia. Multivariate logistic analysis showed that overexpression of p53 [odds ratio (OR) = 13.1, P = 0.004], H. pylori infection (OR = 0.19, P = 0.066), and diastolic BP (OR = 0.87, P = 0.021) were independent risk factors for epithelial dysplasia in BE patients with the SCE type. CONCLUSION Overexpression of p53 is a risk factor for dysplasia of BE, however, H. pylori infection and diastolic BP inversely associated with BE dysplasia might be protective.


Proceedings of the National Academy of Sciences of the United States of America | 1997

Hypo-phosphorylation of the retinoblastoma protein (pRb) by cyclin D:Cdk4/6 complexes results in active pRb.

Sergei A. Ezhevsky; Hikaru Nagahara; Adita M. Vocero-Akbani; David Gius; Michael C. Wei; Steven F. Dowdy


Cancer Research | 1999

Transduced p16INK4a Peptides Inhibit Hypophosphorylation of the Retinoblastoma Protein and Cell Cycle Progression Prior to Activation of Cdk2 Complexes in Late G1

David Gius; Sergei A. Ezhevsky; Michelle Becker-Hapak; Hikaru Nagahara; Michael C. Wei; Steven F. Dowdy


Proceedings of the National Academy of Sciences of the United States of America | 1999

Transforming growth factor β targeted inactivation of cyclin E:cyclin-dependent kinase 2 (Cdk2) complexes by inhibition of Cdk2 activating kinase activity

Hikaru Nagahara; Sergei A. Ezhevsky; Adamina Vocero-Akbani; Philipp Kaldis; Mark J. Solomon; Steven F. Dowdy


Journal of Gastroenterology | 2009

High-sensitivity C-reactive protein as a serum predictor of nonalcoholic fatty liver disease based on the Akaike Information Criterion scoring system in the general Japanese population.

Tomomi Kogiso; Yuriko Moriyoshi; Satoru Shimizu; Hikaru Nagahara; Keiko Shiratori


Journal of Gastroenterology | 2009

Nonalcoholic fatty liver is a risk factor for postprandial hyperglycemia, but not for impaired fasting glucose

Tomoko Shiga; Yuriko Moriyoshi; Hikaru Nagahara; Keiko Shiratori

Collaboration


Dive into the Hikaru Nagahara's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Tomomi Kogiso

International University of Health and Welfare

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Sergei A. Ezhevsky

Washington University in St. Louis

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Adamina Vocero-Akbani

Washington University in St. Louis

View shared research outputs
Top Co-Authors

Avatar

David Gius

Washington University in St. Louis

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Michelle Becker-Hapak

Washington University in St. Louis

View shared research outputs
Researchain Logo
Decentralizing Knowledge